The 83,557insA variant of the gene coding 11β-hydroxysteroid dehydrogenase type 1 enzyme associates with serum osteocalcin in patients with endogenous Cushing's syndrome

Journal of Steroid Biochemistry and Molecular Biology

Volumn 123, Issue 1-2, 2011, Pages 79-84

  Szappanos, Ágnes ^a   Patócs, Attila ^a,b   Gergics, Péter ^a   Bertalan, Rita ^a   Kerti, Andrea ^a   Ács, Bence ^a   Feldmann, Karolina ^a   Rácz, Károly ^a   Tóth, Miklós ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; 83,557insA; Bone marker; Hypercortisolism; Polymorphism

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; CORTICOTROPIN; OSTEOCALCIN;

ADRENAL TUMOR; ALLELE; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROIMMUNOASSAY; GENETIC CODE; GENOTYPE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADENOMA; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; BONE DENSITY; CUSHING SYNDROME; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; POLYMORPHISM, GENETIC;

EID: 78650562305     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.11.009     Document Type: Article

References (32)

1. A.G. Atanasov, and A. Odermatt Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity? Endocr. Metab. Immune Disord. Drug Targets 7 2 2007 125 140
2. J.W. Tomlinson, E.A. Walker, I.J. Bujalska, N. Draper, G.G. Lavery, M.S. Cooper, M. Hewison, and P.M. Stewart 11Beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response Endocr. Rev. 25 5 2004 831 866
3. N. Draper, and P.M. Stewart 11Beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action J. Endocrinol. 186 2 2005 251 271
4. P. Anagnostis, V.G. Athyros, K. Tziomalos, A. Karagiannis, and D.P. Mikhailidis Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis J. Clin. Endocrinol. Metab. 94 8 2009 2692 2701
5. N.A. Huizenga, J.W. Koper, P. de Lange, H.A. Pols, R.P. Stolk, D.E. Grobbee, F.H. de Jong, and S.W. Lamberts Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals J. Clin. Endocrinol. Metab. 83 1998 47 54
6. R.H DeRijk, M. Schaaf, and E.R. de Kloet Glucocorticoid receptor variants: clinical implications J. Steroid Biochem. Mol. Biol. 81 2002 103 122
7. S. Wüst, E.F. Van Rossum, I.S. Federenko, J.W. Koper, R. Kumsta, and D.H. Hellhammer Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress J. Clin. Endocrinol. Metab. 89 2 2004 565 573
8. G.M. Tannin, A.K. Agarwal, C. Monder, M.I. New, and P.C. White The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization J. Biol. Chem. 266 25 1991 16653 16658
9. L. Gelernter-Yaniv, N. Feng, N.G. Sebring, Z. Hochberg, and J.A. Yanovski Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition Int. J. Obes. Relat. Metab. Disord. 27 8 2003 983 986
10. P.W. Franks, W.C. Knowler, S. Nair, J. Koska, Y.H. Lee, R.S. Lindsay, B.R. Walker, H.C. Looker, P.A. Permana, P.A. Tataranni, and R.L. Hanson Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians Hypertension 44 5 2004 681 688
11. S. Nair, Y.H. Lee, R.S. Lindsay, B.R. Walker, P.A. Tataranni, C. Bogardus, L.J. Baier, and P.A. Permana 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle Diabetologia 47 6 2004 1088 1095
12. A. Gambineri, V. Vicennati, S. Genghini, F. Tomassoni, U. Pagotto, R. Pasquali, and B.R. Walker Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 91 6 2006 2295 2302
13. D.J. de Quervain, R. Poirier, M.A. Wollmer, L.M. Grimaldi, M. Tsolaki, J.R. Streffer, C. Hock, R.M. Nitsch, M.H. Mohajeri, and A. Papassotiropoulos Glucocorticoid-related genetic susceptibility for Alzheimer's disease Hum. Mol. Genet. 13 1 2004 47 52
14. N. Draper, E.A. Walker, I.J. Bujalska, J.W. Tomlinson, S.M. Chalder, W. Arlt, G.G. Lavery, O. Bedendo, D.W. Ray, I. Laing, E. Malunowicz, P.C. White, M. Hewison, P.J. Mason, J.M. Connell, C.H. Shackleton, and P.M. Stewart Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency Nat. Genet. 34 4 2003 434 439
15. J.L. San Millán, J.I. Botella-Carretero, F. Alvarez-Blasco, M. Luque-Ramírez, J. Sancho, P. Moghetti, and H.F. Escobar-Morreale A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome J. Clin. Endocrinol. Metab. 90 7 2005 4157 4162
16. P. Smit, M.J. Dekker, F.J. de Jong, A.W. van den Beld, J.W. Koper, H.A. Pols, A.O. Brinkmann, F.H. de Jong, M.M. Breteler, and S.W. Lamberts Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia J. Clin. Endocrinol. Metab. 92 1 2007 359 362
17. A.C. Looker, H.W. Wahner, W.L. Dunn, M.S. Calvo, T.B. Harris, S.P. Heyse, C.C. Johnston Jr., and R.L. Lindsay Proximal femur bone mineral levels of US adults Osteoporos Int. 5 5 1995 389 409
18. R. Pasquali, V. Vicennati, M. Cacciari, and U. Pagotto The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome Ann. N.Y. Acad. Sci. 1083 2006 111 128 (Pubitemid 44955469)
19. B.R. Walker Cortisol - cause and cure for metabolic syndrome? Diabet. Med. 23 12 2006 1281 1288
20. E.F. van Rossum, and S.W. Lamberts Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition Recent Prog. Horm. Res. 59 2004 333 357
21. P.J. Bray, and R.G. Cotton Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms Hum Mutat. 21 6 2003 557 568
22. A. Szappanos, A. Patócs, J. Tõke, B. Boyle, M. Sereg, J. Majnik, G. Borgulya, I. Varga, I. Likó, K. Rácz, and M. Tóth BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism Clin. Endocrinol. (Oxf). 71 5 2009 636 643
23. J.Y. Hwang, S.H. Lee, G.S. Kim, J.M. Koh, M.J. Go, Y.J. Kim, H.C. Kim, T.H. Kim, J.M. Hong, E.K. Park, J.Y. Lee, and S.Y. Kim HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia Bone 45 6 2009 1098 1103
24. L. Füto, J. Toke, A. Patócs, A. Szappanos, I. Varga, E. Gláz, Z. Tulassay, K. Rácz, and M. Tóth Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome Osteoporos Int. 19 7 2008 941 949
25. A. Szappanos, J. Toke, D. Lippai, A. Patócs, P. Igaz, N. Szücs, L. Füto, E. Gláz, K. Rácz, and M. Tóth Bone turnover in patients with endogenous Cushing's syndrome before and after successful treatment Osteoporos Int. 21 4 2010 637 645
26. S. Pierotti, L. Gandini, A. Lenzi, and A.M. Isidori Pre-receptorial regulation of steroid hormones in bone cells: insights on glucocorticoid-induced osteoporosis J. Steroid Biochem. Mol. Biol. 108 3-5 2008 292 299
27. M.S. Cooper, E.A. Walker, R. Bland, W.D. Fraser, M. Hewison, and P.M. Stewart Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone Bone 27 3 2000 375 381
28. T. Tateno, H. Izumiyama, M. Doi, T. Yoshimoto, M. Shichiri, N. Inoshita, K. Oyama, S. Yamada, and Y. Hirata Differential gene expression in ACTH -secreting and non-functioning pituitary tumors Eur. J. Endocrinol. 157 6 2007 717 724
29. T. Nigawara, Y. Iwasaki, M. Asai, M. Yoshida, M. Kambayashi, H. Sashinami, K. Hashimoto, and T. Suda Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells Endocrinology 147 2 2006 769 772
30. M. Korbonits, I. Bujalska, M. Shimojo, J. Nobes, S. Jordan, A.B. Grossman, and P.M. Stewart Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors J. Clin. Endocrinol. Metab. 86 6 2001 2728 2733
31. M.L. Ricketts, J.M. Verhaeg, I. Bujalska, A.J. Howie, W.E. Rainey, and P.M. Stewart Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues J Clin Endocrinol Metab. 83 4 1998 1325 1335
32. T. Mune, H. Morita, T. Suzuki, Y. Takahashi, Y. Isomura, T. Tanahashi, H. Daido, N. Yamakita, T. Deguchi, H. Sasano, P.C. White, and K. Yasuda Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas J. Clin. Endocrinol. Metab. 88 2 2003 864 870